Targeting IL-17A: A Winner in PsA (CME/CE)

(MedPage Today) — Ixekizumab was effective in patients who had failed TNF inhibitors Source: Dermatology

(MedPage Today) — Ixekizumab was effective in patients who had failed TNF inhibitors
Source: Dermatology

Leave a Reply